An alarming revelation has surfaced: In 2020, the FDA, HHS, and Department of Justice approved Pfizer’s mRNA COVID-19 vaccine despite allegations of fraud during its clinical trials. As reported by the Vigilant Fox, this came to light in whistleblower Brook Jackson’s interview with Maria Zee, posted on May 5, 2025—where Jackson revealed that the government declined to investigate the fraud because doing so would conflict with its health policy.
Jackson worked for 18 days as regional director for Ventavia, the company that ran the vaccine trial sites for Pfizer. That amount of time, she said, was enough for her to witness widespread fraud.
Jackson said the entire operation was riddled with serious violations. She saw falsified data, trial participants who were unblinded, staff who were poorly trained, and vaccines that were improperly stored.
She witnessed many adverse events, which were essentially ignored.
Worse, she claimed the company FAILED to follow up on adverse events, including serious, potentially life-threatening ones—which recklessly endangered patients and destroyed the integrity of the entire trial.
Pfizer, she said, was aware of the adverse events.
“We were so inundated with the number of adverse events that we could not keep up,” she said. Pfizer even called asking what the plan was to handle the flood of safety reports.
She said patients weren’t even given full informed consent—her “number one concern.”
When Ventavia refused to listen to her concerns and investigate, she went to the FDA. Six hours later she was fired for not being “a good fit.”
The Gold Report is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
In 2021, Jackson filed suit under the False Claims Act, alleging that “Pfizer, Ventavia, and others committed fraud by falsifying data and violating clinical trial protocols.”
In a new legal challenge, Jackson is now suing the U.S. government itself. According to court papers, as Zee read during the interview, the government had three arguments against the lawsuit. First, the FDA was aware of the alleged violations before it approved the vaccine’s emergency use authorization (EUA). Second, the FDA “had continued access” to the clinical trial data and, in its opinion, the vaccine was effective. The third, and perhaps most shocking, reason offered by the government is support of its request to dismiss the lawsuit was that investigating the allegations would be “inconsistent with its health policy” (video clip below).
The most disturbing admission of all comes in the third point of the case.
The court filing states:
“The government further explained that discovery and litigation obligations associated with the case would place significant burdens on FDA, HHS, and the Department of Justice and that the government should not be required to bear such burdens on a case‘inconsistent with its health policy.’”
In plain English: the government didn’t want to investigate Pfizer, not because the fraud claims lacked merit, but because digging deeper would conflict with its official narrative that the COVID shots are “effective.”
That’s the health policy they’re clinging to.
And they'd rather bury anything that threatens to expose flaws, fraud, or harm from these shots than face the fallout of their own actions. (Original emphasis.)
Jackson wondered how exposing fraud goes against public health policy.
Fraud Suits a Regular Occurrence
In addition to her case in which the FDA failed to take action despite knowledge of fraud, Jackson noted on her X account a variety of other instances of medical manufacturer fraud, some of which the FDA was aware of and failed to act upon, and some of which the company hid from the agency, including:
D’Agostina v ev3, Inc
. . . “It is implausible that the FDA would have pulled the product from the market or refused to pay for it merely because of the alleged fraud.”—Judge Bruce M. Selya, delivering the opinion of the court.
The court ruled that because the FDA didn’t revoke the device’s approval after the fraud allegations were revealed that it was “implausible” that the fraud was material to the government’s payment decisions.(Emphasis added.)
Gilead imported unapproved, adulterated active pharmaceutical ingredients (API) from China for use in its HIV drugs. Relators claimed Gilead lied to FDA & then sought reimbursement from government programs for drugs that were technically not FDA-approved due to the use of those ingredients.
In 2019, the DOJ stepped in and killed the case. (Emphasis added.)
Petratos alleged that Genentech suppressed data indicating that its cancer drug, Avastin, had more severe side effects than reported, leading to Medicare reimbursements for treatments that were NOT "reasonable and necessary."
FDA continued to approve Avastin for various indications & did not take regulatory action against Genentech despite being informed of the allegations. (Emphasis added.)
An example of the FDA prioritizing policy over safety, which echoes Jackson’s claims, dates back to 1984. In the Federal Register, the FDA openly admitted that public perception, rather than safety, was its top concern regarding the polio vaccine, as I covered for The Gold Report news site:
Here’s the FDA admitting in the June 1984 Federal Register that they may have safety problems with the polio vaccine but doubts "can't be allowed to exist:"
“. . . any possible doubts, whether or not well founded, about the safety of the vaccine cannot be allowed to exist in view of the need to assure that the vaccine will continue to be used to the maximum extent consistent with the nation’s public health objectives.”
>> The nation's health objectives, according to the FDA, do not include vaccine safety.
FDA Regularly Found and Ignored Fraudulent Trial Data
In 2015, Charles Seife and his investigative journalism students at NYU reviewed 78 scientific publications describing clinical trials where FDA inspections found serious misconduct, including fraud. (Their research was also published in JAMA Internal Medicine.) Seife and his class also discovered just how much the FDA did not disclose about the lack of data integrity in clinical trials. The article, entitled “Are Your Medications Safe?,” was published in February 2015. The caption under the feature image asked: “Why would the FDA let claims that have been undermined by fraud appear on drug labels?” In an article for The Gold Report news site on pharma's capture of the FDA, I covered Seife’s study.
Among other things, they discovered that FDA inspections of clinical trials have revealed tremendous amounts of fraud, including “Faked X-ray reports. Forged retinal scans. Phony lab tests. Secretly amputated limbs” yet none of these violations are reported.
Seife explained how far they went to hide the evidence:
“…For more than a decade, the FDA has shown a pattern of burying the details of misconduct. As a result, nobody ever finds out which data is bogus, which experiments are tainted, and which drugs might be on the market under false pretenses. The FDA has repeatedly hidden evidence of scientific fraud not just from the public, but also from its most trusted scientific advisers, even as they were deciding whether or not a new drug should be allowed on the market… For an agency devoted to protecting the public from bogus medical science, the FDA seems to be spending an awful lot of effort protecting the perpetrators of bogus science from the public.”
The agency was also meticulous in making sure that no one looking at the documents would be able to figure out the truth, either.
In the Slate article, Seife commented on the FDA as a captured agency, suggesting this as a possible motive for the FDA to conceal trial fraud and obfuscate when questioned about its deception.
…And despite being called out numerous times over the years for its bad behavior, including from some very pissed-off members of Congress, the agency is stubbornly resistant to change. It’s a sign that the FDA is deeply captured, drawn firmly into the orbit of the pharmaceutical industry that it’s supposed to regulate. We can no longer hope that the situation will get better without firm action from the legislature.
He also made the point that the FDA wants you to have faith that it is doing everything in the best interest of the public.
The FDA wants you to take it on faith that its officials have the public’s best interest at heart. Justification through faith alone might be just fine as a religious doctrine, but it’s not a good foundation for ensuring the safety and effectiveness of our drugs. After all, the whole point of science-based medicine is to keep us from having to make a leap of faith every time we swallow a pill.
A Change of Ideology by FDA Employees Needed
Exposing the fraud and failure within the FDA is just the start. If we’re truly going to rebuild trust, it will take more than new leadership—it will require a complete cultural shift within the agency. A new era of transparency and true “gold-standard” vaccine trials has begun under Health and Human Services Secretary Robert F. Kennedy, Jr., who now faces, along with FDA Director Marty Makary, the formidable task of uprooting the deeply entrenched ideologies within the “captured” agency that have shaped its policies and actions for decades.
